

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 8.70372324 |
| 2 | protein neddylation (GO:0045116) | 8.67591175 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 8.28461049 |
| 4 | glucuronate metabolic process (GO:0019585) | 7.49984109 |
| 5 | uronic acid metabolic process (GO:0006063) | 7.49984109 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 7.27194127 |
| 7 | cellular glucuronidation (GO:0052695) | 6.93795066 |
| 8 | glutathione derivative biosynthetic process (GO:1901687) | 6.89721345 |
| 9 | glutathione derivative metabolic process (GO:1901685) | 6.89721345 |
| 10 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 6.73522733 |
| 11 | one-carbon compound transport (GO:0019755) | 6.64761046 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.43436796 |
| 13 | benzene-containing compound metabolic process (GO:0042537) | 6.37566931 |
| 14 | regulation of platelet aggregation (GO:0090330) | 6.36519976 |
| 15 | blood coagulation, intrinsic pathway (GO:0007597) | 6.10399981 |
| 16 | regulation of platelet activation (GO:0010543) | 6.07230392 |
| 17 | relaxation of cardiac muscle (GO:0055119) | 5.99182130 |
| 18 | adenosine receptor signaling pathway (GO:0001973) | 5.75945501 |
| 19 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.64815427 |
| 20 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.63766316 |
| 21 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 5.55403688 |
| 22 | negative regulation of platelet activation (GO:0010544) | 5.47188896 |
| 23 | platelet aggregation (GO:0070527) | 5.44700234 |
| 24 | negative regulation of norepinephrine secretion (GO:0010700) | 5.37292020 |
| 25 | negative regulation of thymocyte apoptotic process (GO:0070244) | 5.35825042 |
| 26 | response to dietary excess (GO:0002021) | 5.30531101 |
| 27 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.23408915 |
| 28 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.22245975 |
| 29 | regulation of cardioblast proliferation (GO:0003264) | 5.19918156 |
| 30 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 5.19918156 |
| 31 | sensory perception of smell (GO:0007608) | 5.16913513 |
| 32 | negative regulation of heart rate (GO:0010459) | 5.12923982 |
| 33 | lipoxygenase pathway (GO:0019372) | 5.12603843 |
| 34 | low-density lipoprotein particle remodeling (GO:0034374) | 5.10380135 |
| 35 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.09486813 |
| 36 | renal absorption (GO:0070293) | 5.07855988 |
| 37 | sulfate transmembrane transport (GO:1902358) | 4.96674964 |
| 38 | glutathione metabolic process (GO:0006749) | 4.90365744 |
| 39 | response to caffeine (GO:0031000) | 4.82994313 |
| 40 | negative regulation of fatty acid transport (GO:2000192) | 4.74455109 |
| 41 | nucleotide transmembrane transport (GO:1901679) | 4.71137783 |
| 42 | positive regulation of actin filament depolymerization (GO:0030836) | 4.49733168 |
| 43 | positive regulation of mast cell activation (GO:0033005) | 4.37566683 |
| 44 | negative regulation of protein localization to cell surface (GO:2000009) | 4.33842904 |
| 45 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.33186554 |
| 46 | platelet degranulation (GO:0002576) | 4.30625805 |
| 47 | angiogenesis involved in wound healing (GO:0060055) | 4.27996674 |
| 48 | neutrophil activation (GO:0042119) | 4.27325507 |
| 49 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.25233302 |
| 50 | L-ascorbic acid metabolic process (GO:0019852) | 4.22016602 |
| 51 | mesenchyme morphogenesis (GO:0072132) | 4.17401074 |
| 52 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.15404434 |
| 53 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.13710668 |
| 54 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.13368350 |
| 55 | relaxation of muscle (GO:0090075) | 4.09466880 |
| 56 | beta-amyloid metabolic process (GO:0050435) | 4.08404591 |
| 57 | androgen biosynthetic process (GO:0006702) | 4.07711275 |
| 58 | negative regulation of response to food (GO:0032096) | 4.07073744 |
| 59 | negative regulation of appetite (GO:0032099) | 4.07073744 |
| 60 | regulation of integrin activation (GO:0033623) | 4.06783543 |
| 61 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.06232424 |
| 62 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.05489385 |
| 63 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.05396308 |
| 64 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.05396308 |
| 65 | generation of neurons (GO:0048699) | 4.04906630 |
| 66 | regulation of lipoprotein metabolic process (GO:0050746) | 4.03473454 |
| 67 | sulfate transport (GO:0008272) | 4.02902175 |
| 68 | positive regulation of Rho protein signal transduction (GO:0035025) | 4.02056947 |
| 69 | pharyngeal system development (GO:0060037) | 3.98763236 |
| 70 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.89074745 |
| 71 | polyamine biosynthetic process (GO:0006596) | 3.88937973 |
| 72 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.88061306 |
| 73 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.86707166 |
| 74 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.85293408 |
| 75 | positive regulation of macrophage differentiation (GO:0045651) | 3.85099421 |
| 76 | platelet activation (GO:0030168) | 3.84771774 |
| 77 | phenylpropanoid metabolic process (GO:0009698) | 3.83575216 |
| 78 | positive regulation of receptor recycling (GO:0001921) | 3.80374825 |
| 79 | endocardial cushion morphogenesis (GO:0003203) | 3.79618519 |
| 80 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.78476341 |
| 81 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.76003404 |
| 82 | platelet formation (GO:0030220) | 3.75949320 |
| 83 | homotypic cell-cell adhesion (GO:0034109) | 3.74927324 |
| 84 | granulocyte activation (GO:0036230) | 3.74160322 |
| 85 | positive regulation of steroid biosynthetic process (GO:0010893) | 3.73460011 |
| 86 | sulfation (GO:0051923) | 3.73260922 |
| 87 | high-density lipoprotein particle remodeling (GO:0034375) | 3.72313013 |
| 88 | megakaryocyte development (GO:0035855) | 3.71340034 |
| 89 | phospholipid homeostasis (GO:0055091) | 3.69901629 |
| 90 | regulation of norepinephrine secretion (GO:0014061) | 3.68363155 |
| 91 | extracellular fibril organization (GO:0043206) | 3.68021592 |
| 92 | negative regulation of heart contraction (GO:0045822) | 3.65806501 |
| 93 | purinergic receptor signaling pathway (GO:0035587) | 3.60136012 |
| 94 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.57520431 |
| 95 | regulation of cholesterol efflux (GO:0010874) | 3.52845796 |
| 96 | hormone catabolic process (GO:0042447) | 3.52609404 |
| 97 | reverse cholesterol transport (GO:0043691) | 3.52592560 |
| 98 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.52552228 |
| 99 | regulation of endothelial cell differentiation (GO:0045601) | 3.52310374 |
| 100 | positive regulation of blood coagulation (GO:0030194) | 3.49714527 |
| 101 | positive regulation of hemostasis (GO:1900048) | 3.49714527 |
| 102 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.47942954 |
| 103 | bicarbonate transport (GO:0015701) | 3.47048629 |
| 104 | negative regulation of cation channel activity (GO:2001258) | 3.46040026 |
| 105 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.45521113 |
| 106 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.43789687 |
| 107 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.43789687 |
| 108 | mitochondrial calcium ion transport (GO:0006851) | 3.43118341 |
| 109 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.41891623 |
| 110 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.38310129 |
| 111 | cell differentiation involved in metanephros development (GO:0072202) | 3.37824419 |
| 112 | negative regulation of catecholamine secretion (GO:0033604) | 3.36076306 |
| 113 | negative regulation of T cell apoptotic process (GO:0070233) | 3.35691277 |
| 114 | outer ear morphogenesis (GO:0042473) | 3.28369175 |
| 115 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.26497348 |
| 116 | regulation of female receptivity (GO:0045924) | 3.25506664 |
| 117 | autophagic vacuole fusion (GO:0000046) | 3.24339836 |
| 118 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.23925558 |
| 119 | termination of signal transduction (GO:0023021) | 3.22734892 |
| 120 | surfactant homeostasis (GO:0043129) | 3.19469522 |
| 121 | response to food (GO:0032094) | 3.19047311 |
| 122 | polyol transport (GO:0015791) | 3.14566256 |
| 123 | negative regulation of JUN kinase activity (GO:0043508) | 3.14213838 |
| 124 | vesicle targeting (GO:0006903) | 3.13530223 |
| 125 | aorta morphogenesis (GO:0035909) | 3.12398438 |
| 126 | Notch signaling involved in heart development (GO:0061314) | 3.11296969 |
| 127 | positive regulation of coagulation (GO:0050820) | 3.09403955 |
| 128 | plasma membrane fusion (GO:0045026) | 3.08700479 |
| 129 | regulation of phospholipase A2 activity (GO:0032429) | 3.08630823 |
| 130 | thrombin receptor signaling pathway (GO:0070493) | 3.08601016 |
| 131 | regulation of receptor recycling (GO:0001919) | 3.08261130 |
| 132 | regulation of hemostasis (GO:1900046) | 3.05058393 |
| 133 | regulation of blood coagulation (GO:0030193) | 3.05058393 |
| 134 | fibril organization (GO:0097435) | 3.04241903 |
| 135 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.03933041 |
| 136 | spermatid nucleus differentiation (GO:0007289) | 3.03322229 |
| 137 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.01963624 |
| 138 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.01326986 |
| 139 | metanephric mesenchyme development (GO:0072075) | 3.00864707 |
| 140 | cyclooxygenase pathway (GO:0019371) | 2.99183453 |
| 141 | activation of MAPKKK activity (GO:0000185) | 2.96686912 |
| 142 | relaxation of smooth muscle (GO:0044557) | 2.92303428 |
| 143 | negative regulation of stress fiber assembly (GO:0051497) | 2.91388647 |
| 144 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.91333337 |
| 145 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.91333337 |
| 146 | L-phenylalanine catabolic process (GO:0006559) | 2.91295568 |
| 147 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.91295568 |
| 148 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.90477816 |
| 149 | leukocyte degranulation (GO:0043299) | 2.88787551 |
| 150 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.88389007 |
| 151 | chemical homeostasis within a tissue (GO:0048875) | 2.87899178 |
| 152 | phagocytosis, engulfment (GO:0006911) | 2.87007879 |
| 153 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.86469974 |
| 154 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.85677991 |
| 155 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.85489441 |
| 156 | sequestering of actin monomers (GO:0042989) | 2.85486372 |
| 157 | endothelium development (GO:0003158) | 2.84936587 |
| 158 | positive regulation of T cell migration (GO:2000406) | 2.83903096 |
| 159 | sulfur compound transport (GO:0072348) | 2.83783443 |
| 160 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.83531690 |
| 161 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83060483 |
| 162 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.82934565 |
| 163 | positive regulation of mast cell degranulation (GO:0043306) | 2.82934565 |
| 164 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.82793878 |
| 165 | female mating behavior (GO:0060180) | 2.82464783 |
| 166 | negative regulation of osteoblast proliferation (GO:0033689) | 2.80944640 |
| 167 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.80035807 |
| 168 | negative regulation of cell junction assembly (GO:1901889) | 2.79500397 |
| 169 | adenine nucleotide transport (GO:0051503) | 2.79455231 |
| 170 | positive regulation of catenin import into nucleus (GO:0035413) | 2.79064352 |
| 171 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.77389121 |
| 172 | xenobiotic metabolic process (GO:0006805) | 2.77310366 |
| 173 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.77082976 |
| 174 | purine ribonucleotide transport (GO:0015868) | 2.73596986 |
| 175 | prostaglandin metabolic process (GO:0006693) | 2.73456166 |
| 176 | prostanoid metabolic process (GO:0006692) | 2.73456166 |
| 177 | ureteric bud development (GO:0001657) | 2.72973008 |
| 178 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.67848833 |
| 179 | positive regulation of gastrulation (GO:2000543) | 2.65603918 |
| 180 | toxin metabolic process (GO:0009404) | 2.65467634 |
| 181 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.60900511 |
| 182 | establishment of epithelial cell polarity (GO:0090162) | 2.60227383 |
| 183 | hyperosmotic salinity response (GO:0042538) | 2.59703075 |
| 184 | kidney mesenchyme development (GO:0072074) | 2.59009043 |
| 185 | regulation of glomerulus development (GO:0090192) | 2.58863615 |
| 186 | sensory perception of chemical stimulus (GO:0007606) | 2.57894087 |
| 187 | nucleotide transport (GO:0006862) | 2.56170932 |
| 188 | positive regulation of steroid metabolic process (GO:0045940) | 2.55131262 |
| 189 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.53376323 |
| 190 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.52767185 |
| 191 | cell proliferation involved in kidney development (GO:0072111) | 2.52488168 |
| 192 | positive regulation of cation channel activity (GO:2001259) | 2.51477419 |
| 193 | negative regulation of protein acetylation (GO:1901984) | 2.51448603 |
| 194 | purine nucleotide transport (GO:0015865) | 2.48909929 |
| 195 | regulation of podosome assembly (GO:0071801) | 2.48552777 |
| 196 | response to interferon-beta (GO:0035456) | 2.47344931 |
| 197 | response to nitrosative stress (GO:0051409) | 15.7818365 |
| 198 | xenobiotic catabolic process (GO:0042178) | 15.6168620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 5.16511348 |
| 2 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.44068725 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.99439258 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.94425552 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.50523369 |
| 6 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.21701358 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.18784644 |
| 8 | GATA1_19941826_ChIP-Seq_K562_Human | 3.07285450 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.06193934 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.04412103 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.84889435 |
| 12 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.81046934 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.80938979 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.79927046 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.77065775 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.69645291 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.67444308 |
| 18 | GATA2_19941826_ChIP-Seq_K562_Human | 2.67242619 |
| 19 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.62956758 |
| 20 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.55214540 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.50380186 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.45334703 |
| 23 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.35097018 |
| 24 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.18637131 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.18068988 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.17211821 |
| 27 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.16402191 |
| 28 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.11068879 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.10278565 |
| 30 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 2.09668747 |
| 31 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.09460118 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.08416959 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07336788 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06977301 |
| 35 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.06551315 |
| 36 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.01876421 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.96877698 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.95029860 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.93016713 |
| 40 | * TAF15_26573619_Chip-Seq_HEK293_Human | 1.92972230 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89805295 |
| 42 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.86763384 |
| 43 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.86763384 |
| 44 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.86763384 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84961662 |
| 46 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.80051343 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.79946369 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79066000 |
| 49 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.75279511 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74076842 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73531283 |
| 52 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.65101989 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.64068065 |
| 54 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.64068065 |
| 55 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63093531 |
| 56 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.62426443 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62167865 |
| 58 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.60192577 |
| 59 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.59791255 |
| 60 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.59446032 |
| 61 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.59322744 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.58993106 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.56528252 |
| 64 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55456576 |
| 65 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.53658780 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51261726 |
| 67 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.50522583 |
| 68 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.50503790 |
| 69 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.50503790 |
| 70 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.47332433 |
| 71 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.46905538 |
| 72 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.46788479 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45910720 |
| 74 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45811136 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.44091616 |
| 76 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.43839129 |
| 77 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42397719 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41393818 |
| 79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41133036 |
| 80 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40212302 |
| 81 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.38419727 |
| 82 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37715004 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36359397 |
| 84 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36265224 |
| 85 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.36027924 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.35255738 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35156538 |
| 88 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.34714552 |
| 89 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.33662974 |
| 90 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.29643200 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29431293 |
| 92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.26963571 |
| 93 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.26244155 |
| 94 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24849197 |
| 95 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.24526832 |
| 96 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.24099283 |
| 97 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23850233 |
| 98 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23447233 |
| 99 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21462663 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.21247557 |
| 101 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20707378 |
| 102 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.19608469 |
| 103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.19352607 |
| 104 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19082897 |
| 105 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.18942594 |
| 106 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.18891172 |
| 107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17435894 |
| 108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16887453 |
| 109 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16676121 |
| 110 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.16303878 |
| 111 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15838243 |
| 112 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.15247800 |
| 113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15049639 |
| 114 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12841710 |
| 115 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.12841425 |
| 116 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12563742 |
| 117 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10585165 |
| 118 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.09392799 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07701353 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07571651 |
| 121 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.06862688 |
| 122 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06134610 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05977486 |
| 124 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.05200692 |
| 125 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04887119 |
| 126 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04328818 |
| 127 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04278976 |
| 128 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04163570 |
| 129 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02178510 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01617671 |
| 131 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.00025797 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99814310 |
| 133 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99038362 |
| 134 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.98843389 |
| 135 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98460525 |
| 136 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97998028 |
| 137 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97569087 |
| 138 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97292973 |
| 139 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.96856052 |
| 140 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96071682 |
| 141 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95748095 |
| 142 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95148588 |
| 143 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94741141 |
| 144 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93953255 |
| 145 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93845484 |
| 146 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93591481 |
| 147 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93405498 |
| 148 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93226655 |
| 149 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93164240 |
| 150 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92801058 |
| 151 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92360857 |
| 152 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92257830 |
| 153 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91998532 |
| 154 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91998532 |
| 155 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91024735 |
| 156 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90555201 |
| 157 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.90469109 |
| 158 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.90146176 |
| 159 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89685213 |
| 160 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88546187 |
| 161 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87942929 |
| 162 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87673348 |
| 163 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86328892 |
| 164 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86053265 |
| 165 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84527868 |
| 166 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84527025 |
| 167 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.82346385 |
| 168 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82190199 |
| 169 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.81632357 |
| 170 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.81362004 |
| 171 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.80175694 |
| 172 | * OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.79683640 |
| 173 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.77984180 |
| 174 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77914364 |
| 175 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.77757298 |
| 176 | EWS_26573619_Chip-Seq_HEK293_Human | 0.77615849 |
| 177 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.76620857 |
| 178 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.75818262 |
| 179 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.75142587 |
| 180 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.75142587 |
| 181 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.74734048 |
| 182 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73000715 |
| 183 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.72975576 |
| 184 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.72482568 |
| 185 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70303152 |
| 186 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.69305771 |
| 187 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.68991677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008789_abnormal_olfactory_epithelium | 6.19331850 |
| 2 | MP0010030_abnormal_orbit_morphology | 5.94944518 |
| 3 | MP0005499_abnormal_olfactory_system | 5.62274502 |
| 4 | MP0005394_taste/olfaction_phenotype | 5.62274502 |
| 5 | MP0008004_abnormal_stomach_pH | 5.48109242 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.42229508 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 4.20131597 |
| 8 | MP0001984_abnormal_olfaction | 3.60235580 |
| 9 | MP0001346_abnormal_lacrimal_gland | 3.23443855 |
| 10 | MP0006292_abnormal_olfactory_placode | 3.16229181 |
| 11 | MP0000678_abnormal_parathyroid_gland | 3.13534504 |
| 12 | MP0004043_abnormal_pH_regulation | 3.10042531 |
| 13 | MP0009379_abnormal_foot_pigmentation | 3.06723116 |
| 14 | MP0002254_reproductive_system_inflammat | 2.78598977 |
| 15 | MP0004510_myositis | 2.53090822 |
| 16 | MP0000343_altered_response_to | 2.46038749 |
| 17 | MP0003566_abnormal_cell_adhesion | 2.44980727 |
| 18 | MP0000762_abnormal_tongue_morphology | 2.41002090 |
| 19 | MP0002736_abnormal_nociception_after | 2.31828471 |
| 20 | MP0000230_abnormal_systemic_arterial | 2.30812443 |
| 21 | MP0003303_peritoneal_inflammation | 2.22902642 |
| 22 | MP0010368_abnormal_lymphatic_system | 2.20706077 |
| 23 | MP0002233_abnormal_nose_morphology | 2.17198909 |
| 24 | MP0001879_abnormal_lymphatic_vessel | 2.04516136 |
| 25 | MP0004084_abnormal_cardiac_muscle | 2.03878458 |
| 26 | MP0001835_abnormal_antigen_presentation | 2.03876639 |
| 27 | MP0002249_abnormal_larynx_morphology | 2.03374825 |
| 28 | MP0000049_abnormal_middle_ear | 2.02180367 |
| 29 | MP0005464_abnormal_platelet_physiology | 10.5217562 |
| 30 | MP0000534_abnormal_ureter_morphology | 1.96998934 |
| 31 | MP0005410_abnormal_fertilization | 1.92705705 |
| 32 | MP0003638_abnormal_response/metabolism_ | 1.90184621 |
| 33 | MP0000566_synostosis | 1.81346812 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.79088356 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.77698924 |
| 36 | MP0003879_abnormal_hair_cell | 1.72783367 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.72767241 |
| 38 | MP0002234_abnormal_pharynx_morphology | 1.70843582 |
| 39 | MP0008872_abnormal_physiological_respon | 1.70288151 |
| 40 | MP0004130_abnormal_muscle_cell | 1.65576923 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.58675795 |
| 42 | MP0005671_abnormal_response_to | 1.58640961 |
| 43 | MP0001851_eye_inflammation | 1.58412887 |
| 44 | MP0004147_increased_porphyrin_level | 1.57187260 |
| 45 | MP0005365_abnormal_bile_salt | 1.53076765 |
| 46 | MP0009053_abnormal_anal_canal | 1.51362245 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.49983666 |
| 48 | MP0003186_abnormal_redox_activity | 1.49721699 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.49493033 |
| 50 | MP0004036_abnormal_muscle_relaxation | 1.46318837 |
| 51 | MP0002098_abnormal_vibrissa_morphology | 1.43251709 |
| 52 | MP0001968_abnormal_touch/_nociception | 1.41801627 |
| 53 | MP0002733_abnormal_thermal_nociception | 1.40877541 |
| 54 | MP0009250_abnormal_appendicular_skeleto | 1.36656638 |
| 55 | MP0001905_abnormal_dopamine_level | 1.35867210 |
| 56 | MP0001663_abnormal_digestive_system | 1.32967340 |
| 57 | MP0004947_skin_inflammation | 1.31167980 |
| 58 | MP0000613_abnormal_salivary_gland | 1.31090960 |
| 59 | MP0000249_abnormal_blood_vessel | 1.30088174 |
| 60 | MP0002398_abnormal_bone_marrow | 1.27120962 |
| 61 | MP0005000_abnormal_immune_tolerance | 1.26284635 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.22423862 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.22423862 |
| 64 | MP0009763_increased_sensitivity_to | 1.18827588 |
| 65 | MP0004215_abnormal_myocardial_fiber | 1.17277228 |
| 66 | MP0009697_abnormal_copulation | 1.12468727 |
| 67 | MP0003942_abnormal_urinary_system | 1.10053517 |
| 68 | MP0003938_abnormal_ear_development | 1.09706206 |
| 69 | MP0003941_abnormal_skin_development | 1.08761306 |
| 70 | MP0008874_decreased_physiological_sensi | 1.08168245 |
| 71 | MP0003136_yellow_coat_color | 1.06684056 |
| 72 | MP0001270_distended_abdomen | 1.06346149 |
| 73 | MP0005501_abnormal_skin_physiology | 1.06036074 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.04859314 |
| 75 | MP0003937_abnormal_limbs/digits/tail_de | 1.03616645 |
| 76 | MP0000858_altered_metastatic_potential | 1.02387237 |
| 77 | MP0010329_abnormal_lipoprotein_level | 1.01718492 |
| 78 | MP0005409_darkened_coat_color | 0.99961264 |
| 79 | MP0009642_abnormal_blood_homeostasis | 0.98734014 |
| 80 | MP0002751_abnormal_autonomic_nervous | 0.96706649 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.95676527 |
| 82 | MP0002723_abnormal_immune_serum | 0.95147728 |
| 83 | MP0006276_abnormal_autonomic_nervous | 0.94962218 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.94631657 |
| 85 | MP0000681_abnormal_thyroid_gland | 0.94578503 |
| 86 | MP0001970_abnormal_pain_threshold | 0.94574025 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.93840097 |
| 88 | MP0003866_abnormal_defecation | 0.93587743 |
| 89 | MP0000467_abnormal_esophagus_morphology | 0.93407425 |
| 90 | MP0005646_abnormal_pituitary_gland | 0.92299429 |
| 91 | MP0009780_abnormal_chondrocyte_physiolo | 0.92061578 |
| 92 | MP0009764_decreased_sensitivity_to | 0.91555763 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.90789737 |
| 94 | MP0003690_abnormal_glial_cell | 0.90040059 |
| 95 | MP0002429_abnormal_blood_cell | 0.89233084 |
| 96 | MP0005085_abnormal_gallbladder_physiolo | 0.88538708 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 0.88460166 |
| 98 | MP0000689_abnormal_spleen_morphology | 0.86987710 |
| 99 | MP0005165_increased_susceptibility_to | 0.86609697 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.86478841 |
| 101 | MP0003436_decreased_susceptibility_to | 0.86382813 |
| 102 | MP0002972_abnormal_cardiac_muscle | 0.86046728 |
| 103 | MP0005248_abnormal_Harderian_gland | 0.85826926 |
| 104 | MP0005381_digestive/alimentary_phenotyp | 0.85437243 |
| 105 | MP0005023_abnormal_wound_healing | 0.84380960 |
| 106 | MP0002452_abnormal_antigen_presenting | 0.82920421 |
| 107 | MP0001800_abnormal_humoral_immune | 0.82588453 |
| 108 | MP0006138_congestive_heart_failure | 0.82448939 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.81944670 |
| 110 | MP0005408_hypopigmentation | 0.81842399 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 0.80939392 |
| 112 | MP0005385_cardiovascular_system_phenoty | 0.80939392 |
| 113 | MP0004019_abnormal_vitamin_homeostasis | 0.79772788 |
| 114 | MP0003724_increased_susceptibility_to | 0.79646026 |
| 115 | MP0004883_abnormal_blood_vessel | 0.78368021 |
| 116 | MP0003453_abnormal_keratinocyte_physiol | 0.78092005 |
| 117 | MP0003890_abnormal_embryonic-extraembry | 0.77893500 |
| 118 | MP0001664_abnormal_digestion | 0.77119834 |
| 119 | MP0002722_abnormal_immune_system | 0.76657700 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 0.75661683 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.75622105 |
| 122 | MP0001177_atelectasis | 0.75124418 |
| 123 | MP0001845_abnormal_inflammatory_respons | 0.74677144 |
| 124 | MP0002998_abnormal_bone_remodeling | 0.74590203 |
| 125 | MP0004264_abnormal_extraembryonic_tissu | 0.73614829 |
| 126 | MP0002060_abnormal_skin_morphology | 0.73448394 |
| 127 | MP0003755_abnormal_palate_morphology | 0.72937317 |
| 128 | MP0006054_spinal_hemorrhage | 0.72760030 |
| 129 | MP0000383_abnormal_hair_follicle | 0.72736986 |
| 130 | MP0002128_abnormal_blood_circulation | 0.72402059 |
| 131 | MP0002697_abnormal_eye_size | 0.72000563 |
| 132 | MP0008995_early_reproductive_senescence | 0.70413790 |
| 133 | MP0002177_abnormal_outer_ear | 0.70411229 |
| 134 | MP0002420_abnormal_adaptive_immunity | 0.70377600 |
| 135 | MP0002735_abnormal_chemical_nociception | 0.70270626 |
| 136 | MP0009840_abnormal_foam_cell | 0.69279905 |
| 137 | MP0001819_abnormal_immune_cell | 0.69068939 |
| 138 | MP0005174_abnormal_tail_pigmentation | 0.68461165 |
| 139 | MP0000716_abnormal_immune_system | 0.68379592 |
| 140 | MP0002118_abnormal_lipid_homeostasis | 0.67881690 |
| 141 | MP0000358_abnormal_cell_content/ | 0.67238598 |
| 142 | MP0000631_abnormal_neuroendocrine_gland | 0.66752164 |
| 143 | MP0002132_abnormal_respiratory_system | 0.66746012 |
| 144 | MP0002090_abnormal_vision | 0.66621848 |
| 145 | MP0005535_abnormal_body_temperature | 0.66510553 |
| 146 | MP0005620_abnormal_muscle_contractility | 0.66490126 |
| 147 | MP0003279_aneurysm | 0.66067488 |
| 148 | MP0006036_abnormal_mitochondrial_physio | 0.66065197 |
| 149 | MP0005197_abnormal_uvea_morphology | 0.65940682 |
| 150 | MP0003828_pulmonary_edema | 0.65494118 |
| 151 | MP0003011_delayed_dark_adaptation | 0.65351471 |
| 152 | MP0001188_hyperpigmentation | 0.65133617 |
| 153 | MP0005171_absent_coat_pigmentation | 0.65027423 |
| 154 | MP0005187_abnormal_penis_morphology | 0.64594976 |
| 155 | MP0002938_white_spotting | 0.64566390 |
| 156 | MP0004484_altered_response_of | 0.63094374 |
| 157 | MP0005164_abnormal_response_to | 0.63031301 |
| 158 | MP0000685_abnormal_immune_system | 0.63022045 |
| 159 | MP0002876_abnormal_thyroid_physiology | 0.62809955 |
| 160 | MP0000428_abnormal_craniofacial_morphol | 0.62780221 |
| 161 | MP0004134_abnormal_chest_morphology | 0.62663185 |
| 162 | MP0010678_abnormal_skin_adnexa | 0.61945312 |
| 163 | MP0001849_ear_inflammation | 0.60867893 |
| 164 | MP0002295_abnormal_pulmonary_circulatio | 0.60425438 |
| 165 | MP0005388_respiratory_system_phenotype | 0.59761744 |
| 166 | MP0002133_abnormal_respiratory_system | 0.59761744 |
| 167 | MP0000372_irregular_coat_pigmentation | 0.58947832 |
| 168 | MP0001340_abnormal_eyelid_morphology | 0.58670859 |
| 169 | MP0003786_premature_aging | 0.58430503 |
| 170 | MP0000579_abnormal_nail_morphology | 0.57280384 |
| 171 | MP0000465_gastrointestinal_hemorrhage | 0.56233587 |
| 172 | MP0003075_altered_response_to | 0.55609482 |
| 173 | MP0000537_abnormal_urethra_morphology | 0.53762555 |
| 174 | MP0000163_abnormal_cartilage_morphology | 0.53314071 |
| 175 | MP0001485_abnormal_pinna_reflex | 0.52608588 |
| 176 | MP0003385_abnormal_body_wall | 0.52150284 |
| 177 | MP0002557_abnormal_social/conspecific_i | 0.50963837 |
| 178 | MP0005083_abnormal_biliary_tract | 0.49522960 |
| 179 | MP0001502_abnormal_circadian_rhythm | 0.49279314 |
| 180 | MP0001756_abnormal_urination | 0.48071604 |
| 181 | MP0004782_abnormal_surfactant_physiolog | 0.47218021 |
| 182 | MP0009278_abnormal_bone_marrow | 0.47121550 |
| 183 | MP0009672_abnormal_birth_weight | 0.45043624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 9.73884268 |
| 2 | Purpura (HP:0000979) | 9.13571075 |
| 3 | Epistaxis (HP:0000421) | 7.80050905 |
| 4 | Hyperlipoproteinemia (HP:0010980) | 7.17439904 |
| 5 | Gingival bleeding (HP:0000225) | 6.52675693 |
| 6 | Lip pit (HP:0100267) | 6.40929976 |
| 7 | Stomach cancer (HP:0012126) | 5.73267381 |
| 8 | Impaired platelet aggregation (HP:0003540) | 5.57569362 |
| 9 | Abnormal platelet function (HP:0011869) | 5.57569362 |
| 10 | Bifid scrotum (HP:0000048) | 5.36992143 |
| 11 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 4.89734433 |
| 12 | Dyschromatopsia (HP:0007641) | 4.87764881 |
| 13 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 4.77381419 |
| 14 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 4.43930718 |
| 15 | Acanthocytosis (HP:0001927) | 4.41278556 |
| 16 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 4.32121925 |
| 17 | Poikilocytosis (HP:0004447) | 4.29276138 |
| 18 | Abnormality of the middle phalanges of the toes (HP:0010183) | 4.19698006 |
| 19 | Spontaneous hematomas (HP:0007420) | 4.02473740 |
| 20 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 4.02467030 |
| 21 | Conjunctival telangiectasia (HP:0000524) | 3.79845385 |
| 22 | Abnormal pupillary function (HP:0007686) | 3.71401144 |
| 23 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 3.69440089 |
| 24 | Humeroradial synostosis (HP:0003041) | 3.65487401 |
| 25 | Synostosis involving the elbow (HP:0003938) | 3.65487401 |
| 26 | Stenosis of the external auditory canal (HP:0000402) | 3.61198117 |
| 27 | Down-sloping shoulders (HP:0200021) | 3.59652348 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.51042061 |
| 29 | Short middle phalanx of the 5th finger (HP:0004220) | 3.45171706 |
| 30 | Bruising susceptibility (HP:0000978) | 3.38946805 |
| 31 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.38506834 |
| 32 | Paralysis (HP:0003470) | 3.36047152 |
| 33 | Hyperventilation (HP:0002883) | 3.33313238 |
| 34 | Split foot (HP:0001839) | 3.30083183 |
| 35 | Alveolar cell carcinoma (HP:0006519) | 3.28414707 |
| 36 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.27993807 |
| 37 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.18427930 |
| 38 | Aplasia of the phalanges of the hand (HP:0009802) | 3.18427930 |
| 39 | Aplasia involving bones of the extremities (HP:0009825) | 3.18427930 |
| 40 | Abnormal hemoglobin (HP:0011902) | 3.18311477 |
| 41 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.17998185 |
| 42 | Distal lower limb muscle weakness (HP:0009053) | 3.05154800 |
| 43 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.04788524 |
| 44 | Bronchomalacia (HP:0002780) | 3.03100335 |
| 45 | Abnormality of lateral ventricle (HP:0030047) | 3.03065936 |
| 46 | Cheilitis (HP:0100825) | 2.99077428 |
| 47 | Short hallux (HP:0010109) | 2.89390345 |
| 48 | Abnormal auditory evoked potentials (HP:0006958) | 2.88421347 |
| 49 | Hepatoblastoma (HP:0002884) | 2.87699319 |
| 50 | Decreased central vision (HP:0007663) | 2.84643503 |
| 51 | Fibular aplasia (HP:0002990) | 2.83818730 |
| 52 | Morphological abnormality of the middle ear (HP:0008609) | 2.78655252 |
| 53 | Xanthomatosis (HP:0000991) | 2.76371138 |
| 54 | Renal tubular acidosis (HP:0001947) | 2.74824157 |
| 55 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.73924347 |
| 56 | Upper limb muscle weakness (HP:0003484) | 2.73295610 |
| 57 | Abnormality of the 2nd finger (HP:0004100) | 2.71477707 |
| 58 | Short middle phalanx of finger (HP:0005819) | 2.71343855 |
| 59 | Urethral obstruction (HP:0000796) | 2.71251765 |
| 60 | Bowed forearm bones (HP:0003956) | 2.68915389 |
| 61 | Bowing of the arm (HP:0006488) | 2.68915389 |
| 62 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.65163506 |
| 63 | Preauricular pit (HP:0004467) | 2.62372482 |
| 64 | Periauricular skin pits (HP:0100277) | 2.62372482 |
| 65 | Increased density of long bones (HP:0006392) | 2.62050722 |
| 66 | Joint swelling (HP:0001386) | 2.59211302 |
| 67 | Hepatosplenomegaly (HP:0001433) | 2.54207734 |
| 68 | Mesomelia (HP:0003027) | 2.51623230 |
| 69 | Growth hormone excess (HP:0000845) | 2.49638407 |
| 70 | Abnormal pancreas size (HP:0012094) | 2.45612460 |
| 71 | Neoplasm of the adrenal cortex (HP:0100641) | 2.45350576 |
| 72 | Papillary thyroid carcinoma (HP:0002895) | 2.45030979 |
| 73 | Joint hemorrhage (HP:0005261) | 2.43870797 |
| 74 | Male infertility (HP:0003251) | 2.41351933 |
| 75 | Flat acetabular roof (HP:0003180) | 2.40012144 |
| 76 | Increased IgM level (HP:0003496) | 2.39662477 |
| 77 | Plantar hyperkeratosis (HP:0007556) | 2.38692255 |
| 78 | Abnormal sex determination (HP:0012244) | 2.37688661 |
| 79 | Sex reversal (HP:0012245) | 2.37688661 |
| 80 | Short nail (HP:0001799) | 2.37248349 |
| 81 | Ulnar bowing (HP:0003031) | 2.36997895 |
| 82 | Narrow nasal bridge (HP:0000446) | 2.36174208 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.35058521 |
| 84 | Eczematoid dermatitis (HP:0000976) | 2.34085871 |
| 85 | Popliteal pterygium (HP:0009756) | 2.33216821 |
| 86 | Septo-optic dysplasia (HP:0100842) | 2.30986456 |
| 87 | Cupped ear (HP:0000378) | 2.27011971 |
| 88 | Stomatitis (HP:0010280) | 2.26599890 |
| 89 | Tinnitus (HP:0000360) | 2.25876956 |
| 90 | Long clavicles (HP:0000890) | 2.23169835 |
| 91 | Abnormality of cochlea (HP:0000375) | 2.22890755 |
| 92 | Long foot (HP:0001833) | 2.21169452 |
| 93 | Hypoplastic labia majora (HP:0000059) | 2.21161913 |
| 94 | Nausea (HP:0002018) | 2.18798774 |
| 95 | Hydroureter (HP:0000072) | 2.17802366 |
| 96 | Ventricular fibrillation (HP:0001663) | 2.17752320 |
| 97 | Scapular winging (HP:0003691) | 2.17655051 |
| 98 | Sleep apnea (HP:0010535) | 2.17533555 |
| 99 | Short 1st metacarpal (HP:0010034) | 2.17378093 |
| 100 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.17378093 |
| 101 | Abnormality of macrophages (HP:0004311) | 2.16923769 |
| 102 | Thyroid-stimulating hormone excess (HP:0002925) | 2.15938927 |
| 103 | Spontaneous abortion (HP:0005268) | 2.13833152 |
| 104 | Submucous cleft hard palate (HP:0000176) | 2.12509614 |
| 105 | Palmar hyperkeratosis (HP:0010765) | 2.12290867 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 2.09548764 |
| 107 | Abnormality of the renal collecting system (HP:0004742) | 2.09476250 |
| 108 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.08988005 |
| 109 | Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 2.08277038 |
| 110 | Skin pits (HP:0100276) | 2.08142226 |
| 111 | Abnormality of the middle phalanges of the hand (HP:0009833) | 2.07454710 |
| 112 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.04434799 |
| 113 | Hypoplastic scapulae (HP:0000882) | 2.04434799 |
| 114 | Nasolacrimal duct obstruction (HP:0000579) | 2.04098322 |
| 115 | Abnormal ciliary motility (HP:0012262) | 2.02661509 |
| 116 | Median cleft lip (HP:0000161) | 2.02526610 |
| 117 | Palmoplantar hyperkeratosis (HP:0000972) | 2.01859426 |
| 118 | Absent toe (HP:0010760) | 2.00476959 |
| 119 | Prolonged bleeding time (HP:0003010) | 11.9016054 |
| 120 | Menorrhagia (HP:0000132) | 11.1328114 |
| 121 | Increased mean platelet volume (HP:0011877) | 10.8055370 |
| 122 | Abnormal platelet volume (HP:0011876) | 10.1145974 |
| 123 | Advanced eruption of teeth (HP:0006288) | 1.98826280 |
| 124 | Femoral bowing (HP:0002980) | 1.97736741 |
| 125 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.97082350 |
| 126 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.97082350 |
| 127 | Right ventricular cardiomyopathy (HP:0011663) | 1.96651040 |
| 128 | Abnormality of the labia majora (HP:0012881) | 1.95289493 |
| 129 | Tongue fasciculations (HP:0001308) | 1.94569942 |
| 130 | Abnormal glucose tolerance (HP:0001952) | 1.94466412 |
| 131 | Adactyly (HP:0009776) | 1.92781344 |
| 132 | Dysautonomia (HP:0002459) | 1.92605161 |
| 133 | Bifid uvula (HP:0000193) | 1.91851766 |
| 134 | Fragile nails (HP:0001808) | 1.91505951 |
| 135 | Mixed hearing impairment (HP:0000410) | 1.91159874 |
| 136 | Distal lower limb amyotrophy (HP:0008944) | 1.90515237 |
| 137 | Hypophosphatemic rickets (HP:0004912) | 1.90271982 |
| 138 | Male pseudohermaphroditism (HP:0000037) | 1.89271504 |
| 139 | Cutaneous syndactyly (HP:0012725) | 1.88983841 |
| 140 | Pulmonary artery stenosis (HP:0004415) | 1.86490848 |
| 141 | Abnormality of the 1st metacarpal (HP:0010009) | 1.86483128 |
| 142 | Broad-based gait (HP:0002136) | 1.86265879 |
| 143 | Hallux valgus (HP:0001822) | 1.86244604 |
| 144 | Hyperthyroidism (HP:0000836) | 1.85992024 |
| 145 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84438831 |
| 146 | Absent eyebrow (HP:0002223) | 1.84099194 |
| 147 | Ridged nail (HP:0001807) | 1.83658952 |
| 148 | Cutaneous finger syndactyly (HP:0010554) | 1.82692279 |
| 149 | Milia (HP:0001056) | 1.81378786 |
| 150 | Biliary tract neoplasm (HP:0100574) | 1.80329305 |
| 151 | Deviation of the hallux (HP:0010051) | 1.79874256 |
| 152 | Osteolytic defects of the hand bones (HP:0009699) | 1.79671914 |
| 153 | 3-Methylglutaconic aciduria (HP:0003535) | 1.76078781 |
| 154 | Muscle fibrillation (HP:0010546) | 1.75880719 |
| 155 | Arterial thrombosis (HP:0004420) | 1.70556610 |
| 156 | Myocardial infarction (HP:0001658) | 1.70205690 |
| 157 | Episodic fever (HP:0001954) | 1.66288787 |
| 158 | Thyroid carcinoma (HP:0002890) | 1.64956350 |
| 159 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.64794658 |
| 160 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.64794658 |
| 161 | Increased serum ferritin (HP:0003281) | 1.64391532 |
| 162 | Encephalitis (HP:0002383) | 1.62459669 |
| 163 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.60138413 |
| 164 | Polycythemia (HP:0001901) | 1.57996209 |
| 165 | Infertility (HP:0000789) | 1.57871016 |
| 166 | Uterine leiomyosarcoma (HP:0002891) | 1.56960939 |
| 167 | Leiomyosarcoma (HP:0100243) | 1.56960939 |
| 168 | Polyphagia (HP:0002591) | 1.55764702 |
| 169 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.54736889 |
| 170 | Basal ganglia calcification (HP:0002135) | 1.54435118 |
| 171 | Arthropathy (HP:0003040) | 1.53645043 |
| 172 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.52070846 |
| 173 | Vertigo (HP:0002321) | 1.51884551 |
| 174 | Lower limb amyotrophy (HP:0007210) | 1.50164812 |
| 175 | Testicular neoplasm (HP:0010788) | 1.49832372 |
| 176 | Renal Fanconi syndrome (HP:0001994) | 1.49768046 |
| 177 | Obstructive lung disease (HP:0006536) | 1.49323442 |
| 178 | Chronic obstructive pulmonary disease (HP:0006510) | 1.49323442 |
| 179 | Abnormality of the prostate (HP:0008775) | 1.49299952 |
| 180 | Autoimmune hemolytic anemia (HP:0001890) | 1.47270757 |
| 181 | Insidious onset (HP:0003587) | 1.45655541 |
| 182 | Termporal pattern (HP:0011008) | 1.45655541 |
| 183 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.41728260 |
| 184 | Mitral stenosis (HP:0001718) | 1.38392235 |
| 185 | Bladder neoplasm (HP:0009725) | 1.35655046 |
| 186 | Bladder carcinoma (HP:0002862) | 1.35655046 |
| 187 | Back pain (HP:0003418) | 1.35538003 |
| 188 | Abnormality of alanine metabolism (HP:0010916) | 1.34954217 |
| 189 | Hyperalaninemia (HP:0003348) | 1.34954217 |
| 190 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.34954217 |
| 191 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.33864207 |
| 192 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.33113429 |
| 193 | Absent/shortened dynein arms (HP:0200106) | 1.33113429 |
| 194 | Abnormality of the Achilles tendon (HP:0005109) | 1.30125639 |
| 195 | Mucosal telangiectasiae (HP:0100579) | 1.29667626 |
| 196 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.28705888 |
| 197 | Abnormal spermatogenesis (HP:0008669) | 1.28248983 |
| 198 | Central scotoma (HP:0000603) | 1.27616387 |
| 199 | Ileus (HP:0002595) | 1.27375361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.98637420 |
| 2 | RIPK1 | 4.49704562 |
| 3 | MAP3K2 | 3.66405804 |
| 4 | MAP3K3 | 3.45821215 |
| 5 | EIF2AK1 | 3.15676819 |
| 6 | TEC | 2.96565567 |
| 7 | ZAK | 2.93901516 |
| 8 | BTK | 2.91792142 |
| 9 | HIPK2 | 2.86439538 |
| 10 | PTK2B | 2.81910924 |
| 11 | MAP2K2 | 2.79120829 |
| 12 | MKNK2 | 2.72306814 |
| 13 | MAPK15 | 2.58379587 |
| 14 | GRK5 | 2.27105753 |
| 15 | TAOK3 | 2.26769710 |
| 16 | SGK2 | 2.26624307 |
| 17 | EPHB2 | 2.21438762 |
| 18 | CSF1R | 2.17061442 |
| 19 | STK38L | 2.16256794 |
| 20 | MAPKAPK5 | 2.09225150 |
| 21 | SYK | 2.05682601 |
| 22 | PIK3CG | 1.99800177 |
| 23 | ZAP70 | 1.96149986 |
| 24 | PAK3 | 1.87664798 |
| 25 | SGK494 | 1.76860293 |
| 26 | SGK223 | 1.76860293 |
| 27 | GRK6 | 1.75936625 |
| 28 | STK3 | 1.70796354 |
| 29 | RPS6KA4 | 1.58850762 |
| 30 | DYRK3 | 1.56636867 |
| 31 | MST4 | 1.56524728 |
| 32 | BMPR2 | 1.55891511 |
| 33 | MAP3K12 | 1.55320369 |
| 34 | SGK3 | 1.54926410 |
| 35 | INSRR | 1.50989665 |
| 36 | MAP3K14 | 1.50778694 |
| 37 | PDK2 | 1.49639008 |
| 38 | TESK1 | 1.49242303 |
| 39 | EPHB1 | 1.48121833 |
| 40 | PLK2 | 1.40931286 |
| 41 | RPS6KB2 | 1.40222833 |
| 42 | WNK1 | 1.35043653 |
| 43 | DAPK3 | 1.34159977 |
| 44 | PNCK | 1.33213646 |
| 45 | PAK1 | 1.31779294 |
| 46 | ADRBK2 | 1.30967710 |
| 47 | HCK | 1.30610675 |
| 48 | FGFR2 | 1.29623159 |
| 49 | RPS6KA2 | 1.29038277 |
| 50 | NLK | 1.25941137 |
| 51 | MKNK1 | 1.25687821 |
| 52 | CAMK2B | 1.20868390 |
| 53 | PBK | 1.19234046 |
| 54 | CAMK2D | 1.18891390 |
| 55 | ACVR1B | 1.15478493 |
| 56 | NEK6 | 1.13194582 |
| 57 | STK24 | 1.09997737 |
| 58 | DMPK | 1.09433209 |
| 59 | MAPK7 | 1.08763170 |
| 60 | MYLK | 1.07079515 |
| 61 | PIM2 | 1.05946411 |
| 62 | TLK1 | 1.04736021 |
| 63 | PRKG2 | 1.03428123 |
| 64 | LYN | 1.02943819 |
| 65 | RPS6KL1 | 1.02937443 |
| 66 | RPS6KC1 | 1.02937443 |
| 67 | CAMK4 | 1.02089468 |
| 68 | BLK | 0.99176704 |
| 69 | TNK2 | 0.98250095 |
| 70 | FES | 0.96221605 |
| 71 | MAP2K1 | 0.94449678 |
| 72 | SIK1 | 0.93723424 |
| 73 | RPS6KA6 | 0.93690911 |
| 74 | MATK | 0.93479348 |
| 75 | GSK3A | 0.93003450 |
| 76 | CAMK2G | 0.90594378 |
| 77 | FRK | 0.90017405 |
| 78 | BMPR1B | 0.89334801 |
| 79 | ILK | 0.87965363 |
| 80 | DAPK2 | 0.87964471 |
| 81 | RET | 0.86266574 |
| 82 | TRIM28 | 0.86142129 |
| 83 | MAP3K5 | 0.84594859 |
| 84 | ADRBK1 | 0.83915113 |
| 85 | BCKDK | 0.83525893 |
| 86 | ERBB3 | 0.82680970 |
| 87 | ITK | 0.81926232 |
| 88 | PKN1 | 0.78401835 |
| 89 | EPHA2 | 0.77909748 |
| 90 | FER | 0.73786528 |
| 91 | PRPF4B | 0.72715386 |
| 92 | MARK3 | 0.71462086 |
| 93 | ALK | 0.69293904 |
| 94 | TESK2 | 0.69201113 |
| 95 | TXK | 0.68940803 |
| 96 | TAOK2 | 0.67460160 |
| 97 | MINK1 | 0.66218733 |
| 98 | ROCK2 | 0.65006084 |
| 99 | SIK3 | 0.63440612 |
| 100 | ROCK1 | 0.62371545 |
| 101 | ERBB4 | 0.62152013 |
| 102 | IKBKE | 0.61651581 |
| 103 | PDGFRB | 0.60323880 |
| 104 | ERBB2 | 0.60222657 |
| 105 | DAPK1 | 0.59757846 |
| 106 | TAOK1 | 0.59706802 |
| 107 | MARK2 | 0.59481882 |
| 108 | ARAF | 0.58865932 |
| 109 | MAPKAPK2 | 0.56157512 |
| 110 | CSK | 0.56080490 |
| 111 | MAPKAPK3 | 0.54213238 |
| 112 | OXSR1 | 0.54062571 |
| 113 | STK38 | 0.54048287 |
| 114 | TNIK | 0.53135910 |
| 115 | PRKACG | 0.52836010 |
| 116 | STK4 | 0.50077606 |
| 117 | LMTK2 | 0.50045218 |
| 118 | PDK1 | 0.49799713 |
| 119 | IKBKB | 0.48343908 |
| 120 | RPS6KA1 | 0.47725769 |
| 121 | CDK6 | 0.46280105 |
| 122 | LIMK1 | 0.45870436 |
| 123 | MAP4K2 | 0.45565295 |
| 124 | MAP2K3 | 0.44783165 |
| 125 | FGR | 0.44605932 |
| 126 | DYRK1A | 0.44445964 |
| 127 | PRKCE | 0.44273630 |
| 128 | PRKD1 | 0.43472567 |
| 129 | CSNK1G1 | 0.43371407 |
| 130 | EPHA3 | 0.43339392 |
| 131 | IRAK4 | 0.43326930 |
| 132 | MAPK4 | 0.43107371 |
| 133 | PRKG1 | 0.41314000 |
| 134 | FYN | 0.39629439 |
| 135 | CSNK1A1 | 0.39236792 |
| 136 | MAPK13 | 0.38267103 |
| 137 | GRK1 | 0.37869716 |
| 138 | ATR | 0.37394232 |
| 139 | SGK1 | 0.37352918 |
| 140 | CAMK2A | 0.36727341 |
| 141 | PDPK1 | 0.35841701 |
| 142 | AKT2 | 0.35267488 |
| 143 | STK10 | 0.34728770 |
| 144 | BMX | 0.34574386 |
| 145 | TYK2 | 0.34465487 |
| 146 | LCK | 0.34089557 |
| 147 | NUAK1 | 0.33994642 |
| 148 | TTN | 0.33127857 |
| 149 | PRKCD | 0.32552965 |
| 150 | PTK6 | 0.32012573 |
| 151 | IRAK1 | 0.31808928 |
| 152 | CSNK1D | 0.31247287 |
| 153 | YES1 | 0.30018991 |
| 154 | PRKCB | 0.29124543 |
| 155 | MAPK12 | 0.29043105 |
| 156 | CDK14 | 0.28953555 |
| 157 | IRAK2 | 0.27979250 |
| 158 | PRKCA | 0.27624169 |
| 159 | IRAK3 | 0.27554406 |
| 160 | JAK2 | 0.27068562 |
| 161 | JAK1 | 0.26616138 |
| 162 | SRC | 0.26020538 |
| 163 | CLK1 | 0.25835369 |
| 164 | IGF1R | 0.24763190 |
| 165 | PRKCQ | 0.21609937 |
| 166 | CDK8 | 0.20613578 |
| 167 | PAK2 | 0.20390595 |
| 168 | PIM1 | 0.19713445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 6.02153123 |
| 2 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 5.86645679 |
| 3 | Platelet activation_Homo sapiens_hsa04611 | 5.73167148 |
| 4 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 5.08707587 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 4.65633040 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.44385845 |
| 7 | Glutathione metabolism_Homo sapiens_hsa00480 | 4.35416578 |
| 8 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 4.08625625 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.54296208 |
| 10 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.48781128 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.48158842 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.26690442 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.17222593 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.87391883 |
| 15 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.85360749 |
| 16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.82916612 |
| 17 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.80847339 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75150017 |
| 19 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.71094920 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.65280885 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65246863 |
| 22 | Alcoholism_Homo sapiens_hsa05034 | 1.59670409 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.58838555 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.57544490 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51031872 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.48840199 |
| 27 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.45738115 |
| 28 | Endocytosis_Homo sapiens_hsa04144 | 1.40502515 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37481124 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.35710012 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.26929716 |
| 32 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.24551425 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23836259 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15109762 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.12129562 |
| 36 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.11682217 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11577367 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10420060 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08712109 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.07630125 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03834075 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.00282284 |
| 43 | Long-term depression_Homo sapiens_hsa04730 | 0.99404943 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94418529 |
| 45 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93244714 |
| 46 | Prostate cancer_Homo sapiens_hsa05215 | 0.92859066 |
| 47 | Olfactory transduction_Homo sapiens_hsa04740 | 0.92006571 |
| 48 | Focal adhesion_Homo sapiens_hsa04510 | 0.91623111 |
| 49 | Morphine addiction_Homo sapiens_hsa05032 | 0.91049752 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90259946 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89390033 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86523327 |
| 53 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84280261 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83582669 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75769214 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.74495302 |
| 57 | Mismatch repair_Homo sapiens_hsa03430 | 0.73011966 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.71528557 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70972593 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70658162 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69807984 |
| 62 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.68874516 |
| 63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68186289 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67631019 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67313822 |
| 66 | GABAergic synapse_Homo sapiens_hsa04727 | 0.66849786 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.66108218 |
| 68 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.65068365 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.64192661 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.63968537 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63088676 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62954663 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61161800 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.60794831 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60382554 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60333941 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58908453 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56301624 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55980021 |
| 80 | Melanoma_Homo sapiens_hsa05218 | 0.55398712 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54018224 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.53494871 |
| 83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51107456 |
| 84 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51088893 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.50613097 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50370995 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49976184 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48604873 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48403069 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.47967199 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47375819 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47272264 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.46208155 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46031429 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.45459317 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.45407685 |
| 97 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.45269851 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43176378 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43134231 |
| 100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43101138 |
| 101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41952047 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41928283 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41274498 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.39945016 |
| 105 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.39520047 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.38899942 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38447644 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38285358 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38002361 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36954077 |
| 111 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36940219 |
| 112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35813239 |
| 113 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34970225 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34673220 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34662445 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34497570 |
| 117 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.34227721 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.33833568 |
| 119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33292631 |
| 120 | Circadian entrainment_Homo sapiens_hsa04713 | 0.33092916 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33057343 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.33042543 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.31801768 |
| 124 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31255172 |
| 125 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.30506111 |
| 126 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30430507 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29908687 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29543338 |
| 129 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28758792 |
| 130 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.28404380 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.27717675 |
| 132 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.27201570 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27035448 |
| 134 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.25996310 |
| 135 | Renin secretion_Homo sapiens_hsa04924 | 0.25398062 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24815377 |
| 137 | Peroxisome_Homo sapiens_hsa04146 | 0.24405811 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24194794 |
| 139 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.23968733 |
| 140 | Phagosome_Homo sapiens_hsa04145 | 0.23378527 |
| 141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.23011541 |
| 142 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22313515 |
| 143 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.22088745 |
| 144 | Pertussis_Homo sapiens_hsa05133 | 0.22005890 |
| 145 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.21727018 |
| 146 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21679765 |
| 147 | Tight junction_Homo sapiens_hsa04530 | 0.21432124 |
| 148 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.21009670 |
| 149 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.20836257 |
| 150 | Leishmaniasis_Homo sapiens_hsa05140 | 0.20656064 |
| 151 | Insulin secretion_Homo sapiens_hsa04911 | 0.20508550 |
| 152 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17615190 |
| 153 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.17067922 |
| 154 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.16714227 |
| 155 | Gap junction_Homo sapiens_hsa04540 | 0.16382642 |
| 156 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.16288354 |
| 157 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15528116 |
| 158 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.15052230 |
| 159 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.14986579 |
| 160 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.13632768 |
| 161 | Salivary secretion_Homo sapiens_hsa04970 | 0.13294533 |
| 162 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.13196804 |
| 163 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.13034476 |
| 164 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.12622595 |
| 165 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.12537036 |
| 166 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.11963373 |

